Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028
... CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028 Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated ... Read More
-
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Mouthpiece PEP Devices, Face Mask PEP Devices, and Bottle PEP Devices), Indication [Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others], and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)
... Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others], and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) The oscillating positive expiratory pressure (OPEP) devices market is expected to grow from US$ 125.66 million in 2021 ... Read More
-
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
South and Central America Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The South and Central America carbapenem-based antibiotics market is expected to reach US$ 360.29 million by 2028 from US$ 281.43 ... Read More
-
Anesthesia and Respiratory Devices Market (Product Type: Anesthesia Devices [Anesthesia Machines and Anesthesia Disposables] and Respiratory Devices [Respiratory Equipment, Respiratory Disposables, and Respiratory Measurement Devices]; and End-user: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Anesthesia and Respiratory Devices Market – Scope of Report TMR’s report on the global anesthesia and respiratory devices market studies the past as well as the current ... Read More
-
Bronchoscopy Market Size By Product Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Product Usage (Single Use/ Disposable, Reusable), By Age Group (Adult, Pediatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Forecast, 2022 - 2028 The global bronchoscopy market is expected to grow exponentially by 2028 on account of rising prevalence of lung cancer due to surging rates of indoor and outdoor air pollution. Bronchoscopy is ... Read More
-
Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 ... Read More
-
Europe Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Europe carbapenem-based antibiotics market is expected to reach US$ 1,469.86 million by 2028 from US$ 1,128.37 million in 2021; it is estimated ... Read More
-
Asia Pacific Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Asia Pacific carbapenem-based antibiotics market is expected to reach US$ 1,506.07 million by 2028 from US$ 1,072.76 million in 2021; it ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The Asia Pacific non-invasive ventilation masks market is expected to reach US$ 581.8 million by 2028 from US$ 384.8 million in 2021. The market is ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... and End User (Pediatric, ICU, Home Care, and Others) The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is ... Read More
-
South and Central America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The South & Central America non-invasive ventilation masks market is expected to reach US$ 166.2 million by 2028 from US$ 119.8 million in ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
North America Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it ... Read More
-
Bacteriophage Market
... assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the bacteriophage market, growth prospects of the market are obtained with maximum precision. The ... Read More
-
2022-2026 Global Respiratory Syncytial Virus (RSV) Diagnostic Testing Market: US, Europe, Japan-Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year ... Read More
-
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank
... from 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. ... Read More
-
North America Respiratory Protective Equipment Market Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Product Markets Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
2022 Global In Vitro Lung Model Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Global Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Latin America, Middle East & Africa Respiratory Protective Equipment Market Databank
... CAGR of 3.69% from 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, ... Read More
Research Assistance
